| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 03/21/2002 | WO2001087846A3 Tricyclic pyrazole derivatives as protein kinase inhibitors |
| 03/21/2002 | WO2001068568A3 Il-8 receptor antagonists |
| 03/21/2002 | WO2001066099A3 Use of quinazoline derivatives as angiogenesis inhibitors |
| 03/21/2002 | US20020035121 Aryl fused substituted 4-oxy-pyridines |
| 03/21/2002 | US20020034658 Organic electroluminescent device comprising dipyridylthiophene derivative |
| 03/21/2002 | CA2418720A1 Caspase inhibitors and uses thereof |
| 03/20/2002 | EP1188755A1 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 03/19/2002 | US6359151 Use as pesticides. |
| 03/19/2002 | US6359111 Useful in treating cancer, and in a method of imaging opioid receptors either inside or outside of the central nervous system |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/19/2002 | US6358887 2-Phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides |
| 03/19/2002 | US6358689 Detection of markers in nascent proteins |
| 03/19/2002 | US6358634 Nitrogen-containing heterocyclic compound, organic light-emitting device material and organic light-emitting device |
| 03/19/2002 | CA2128359C New benzospiroalkene derivatives, their preparation process and pharmaceutical compositions containing them |
| 03/19/2002 | CA2128287C Benzospiroalkene derivatives, their preparation process and pharmaceutical compositions containing them |
| 03/14/2002 | WO2002020530A1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 03/14/2002 | WO2002020529A1 Method for obtaining 4-(n-alkylamine)-5, 6-dihydro-4h-thieno-(2,3-b)-thiopyran-2-sulfamide-7, 7-dioxides and intermediate products |
| 03/14/2002 | WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | WO2002020442A1 Method for hydrogenating c-c double bonds |
| 03/14/2002 | US20020032332 Hypotensive agents, antiallergens, antiasthma, treating bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorder, gastrointestinal motility or cardiovascular disorders |
| 03/14/2002 | US20020032219 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
| 03/14/2002 | US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 03/14/2002 | DE10135681A1 Hydrierverfahren Hydrogenation |
| 03/14/2002 | DE10042997A1 Thienopyrimidine Thienopyrimidines |
| 03/14/2002 | CA2421172A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | CA2417594A1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 03/13/2002 | EP1186605A1 Organic electroluminescent device comprising dipyridylthiophene derivative |
| 03/13/2002 | EP1185535A1 Cyclocarbamate and cyclic amide derivatives |
| 03/13/2002 | EP1185534A1 Benzopyrans annelated in c7-c8 with an aromatic heterocycle and compositions and (co)polymer matrices containing them |
| 03/13/2002 | EP0596897B1 Hydroisoquinoline derivatives |
| 03/13/2002 | CN1080723C Production of optically active benzothiepin salts |
| 03/13/2002 | CN1080719C Substituted 1H-3-aryl-pyrrolidine-2,4-diones derivatives |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355672 Bone disorders; central nervous system disorders |
| 03/12/2002 | US6355660 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/12/2002 | US6355647 3-substituted 3,4,5,7-tetrahedropyrrolo[3′,4′:4,5]thieno-[2,3-d]pyrimidine derivatives, their preparation and use |
| 03/12/2002 | US6355443 4-(4-hydroxystyryl) pyridine-containing substrates for an analyte dependent enzyme activation system |
| 03/12/2002 | CA2055947C Condensed heterocyclic compounds, their production and use |
| 03/07/2002 | WO2002018390A1 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine |
| 03/07/2002 | WO2002018389A2 Thienopyrimidine |
| 03/07/2002 | WO2002018383A2 Aza heterocyclic derivatives and their therapeutic use |
| 03/07/2002 | WO2002018357A1 A ONE-POT PROCESS FOR THE PREPARATION OF PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS OF 4, 5, 6, 7 - TETRAHYDROTHIENO (3,2-c) PYRIDINE DERIVATIVES HAVING ANTITHROMBOTIC ACTIVITY |
| 03/07/2002 | WO2002017924A1 Method of treatment |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028841 Thienopyrrolidinones |
| 03/07/2002 | US20020028829 Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
| 03/07/2002 | US20020028823 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same |
| 03/07/2002 | US20020028815 Novel multicyclic compounds and the use thereof |
| 03/07/2002 | CA2420987A1 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine |
| 03/06/2002 | EP1184379A1 Chromene compound |
| 03/06/2002 | CN1338458A Ticlid acetylsalicylate, and its preparing process and medical application |
| 03/06/2002 | CN1080258C 1-H-3-arylpyrrolidine-2,4-dione derivatives as pest-control agents |
| 03/05/2002 | US6353002 Therapeutic agents |
| 03/05/2002 | US6352999 Drugs for nervous system disorders, parkinson's disease and antidepressants |
| 03/05/2002 | US6352984 For treatment of psychological disorders, schizophrenia |
| 02/28/2002 | WO2002016571A1 Magnetic particles having lower limit critical solution temperature |
| 02/28/2002 | WO2002016370A1 1h-imidazopyridine derivatives |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | WO2001042216A3 Caspase inhibitors and uses thereof |
| 02/28/2002 | US20020026051 Calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstriction activity |
| 02/28/2002 | US20020026047 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation |
| 02/28/2002 | US20020025961 Platelet ADP receptor inhibitors |
| 02/28/2002 | US20020025960 Heterocycle carboxamides as antiviral agents |
| 02/27/2002 | EP1181297A1 Cyclohexenone dioxothiochromanoyl derivatives |
| 02/27/2002 | EP1181296A1 Cell adhesion-inhibiting antiinflammatory compounds |
| 02/27/2002 | EP1181295A2 Tricyclic benzoylcyclohexanedione derivatives |
| 02/27/2002 | EP1181279A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 02/27/2002 | EP0892789B1 Irreversible inhibitors of tyrosine kinases |
| 02/27/2002 | CN1079798C 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as antiparasitic agents, and the intermediate |
| 02/26/2002 | CA2128119C Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/21/2002 | WO2002014324A2 Diazepinones as antiviral agents |
| 02/21/2002 | WO2002014305A2 Design and synthesis of advanced nlo materials for electro-optic applications |
| 02/21/2002 | WO2002014269A2 2,4-substituted pyridine derivatives |
| 02/21/2002 | WO2002006247A8 Substituted amidoalkyl-uracils as parp inhibitors |
| 02/21/2002 | US20020022729 Pyridylfuran and pyridylthiophene compounds |
| 02/21/2002 | US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 02/21/2002 | US20020022575 Dialkyl-halogenophenyl-substituted ketoenols |
| 02/21/2002 | CA2419820A1 Design and synthesis of advanced nlo materials for electro-optic applications |
| 02/21/2002 | CA2418853A1 2,4-substituted pyridine derivatives |
| 02/19/2002 | US6348474 Compounds as antidiabetic agents |
| 02/19/2002 | US6348458 Polymorphic forms of olanzapine |
| 02/19/2002 | US6348455 Compound for treatment of psychosis |
| 02/14/2002 | WO2002012249A2 Substituted pyrrole compounds and their use as spla2 inhibitors |
| 02/14/2002 | WO2002012227A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012198A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 02/14/2002 | WO2002012195A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
| 02/14/2002 | WO2002012189A1 Fused bicyclic amide compounds and medicinal use thereof |
| 02/14/2002 | US20020019529 Thienopyridine derivatives, their intermediates and production thereof |
| 02/14/2002 | US20020019412 Antidiabetic agents |
| 02/14/2002 | US20020019390 Imidazole and imidazoline derivatives and uses thereof |
| 02/14/2002 | CA2419030A1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 02/14/2002 | CA2417816A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
| 02/14/2002 | CA2416525A1 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 02/13/2002 | EP1178982A1 Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 02/13/2002 | CN1335846A Pyrano, piperidino and thiopyrano compounds and methods of use |
| 02/13/2002 | CN1335836A Tricyclic pyrazole derivatives |
| 02/12/2002 | US6346536 Benzopyranoisoquinolone derivatives; neurodegenerative and brain disorders; reperfusion injuries; antiischemic agents |
| 02/12/2002 | US6346528 Side effect reduction compared to olanzapine; capsules or tablets; psychological, gastrointestinal and bipolar disorders; anxiolytic agents, antidepressants |
| 02/12/2002 | US6346521 Osteogenesis promoters for bone disorders |
| 02/07/2002 | WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |